Ex parte COLSON et al. - Page 3




          Appeal No. 97-2089                                                          
          Application No. 08/097,801                                                  

               We refer to the brief and to the answer for a complete                 
          discussion by the appellants and the examiner respectively of               
          their contrary viewpoints concerning the above noted                        
          rejection.                                                                  
                                       OPINION                                        
               For the reasons which follow, we will sustain this                     
          rejection.                                                                  
               The only arguments advanced by the appellants in their                 
          brief concern (1) the “consisting essentially of” language of               
          method claim 13 and (2) the lack of motivation in Alexander                 
          for deleting compounds from patentee’s antifoaming                          
          composition.  As correctly indicated by the examiner on page 6              
          of the answer, however, neither of these arguments is relevant              
          to the concentrate claims on appeal.  More specifically, the                
          concentrate claims employ the expression “contains” (rather                 
          than the “consisting essentially of” language of method claim               
          13) and accordingly do not exclude any of the compounds which               
          make up Alexander’s antifoaming composition.                                
               Under these circumstances, it is clear that the                        
          examiner’s section 103 rejection of concentrate claims 16                   

          concentrate claims 16 through 21.                                           
                                          3                                           





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007